Samsung Medical Center
Small intestine cancer treatment cost in the Republic of Korea typically includes essential diagnostics like a PET-CT scan ranging from $900 to $1,500. Primary treatment options often involve specialized procedures such as hyperthermic intraperitoneal chemotherapy (HIPEC), which costs $23,500 to $35,500. Total expenses depend on the cancer stage, surgical complexity, and hospital tier. Patients can save approximately 40-70% compared to the US. Seoul and Seongnam are the primary cities for this treatment.
Typical Small Intestine Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking high-precision treatment should prioritize centers with advanced robotic infrastructure. Korea University Anam Hospital utilized the world's first robotic oral surgical techniques to minimize visible scarring. For complex abdominal cases, SNUH provides the highest cancer treatment statistics in the country. Samsung Medical Center offers multidisciplinary care with presidential standards, ideal for patients requiring integrated radiation and surgical teams. Large tertiary Seoul hospitals offer the best value for advanced-stage cases through JCI-accredited safety protocols.
| Republic of Korea | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $23,500 | from $22,500 | from $40,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Small intestine resection | - | from $12,150 | from $25,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Radiation therapy for bowel cancer | - | from $5,800 | from $6,885 |
No hidden fees – just official clinic prices. Pay at the clinic for Small intestine cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Small intestine cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Small intestine cancer treatment journey.
Dr. Paik Nam-sun is a surgical oncologist at Ewha Womans University Medical Center in Seoul. He is recognized as one of the world's top 100 gastric and breast cancer surgeons. He performed the first breast-conserving surgery in South Korea. Dr. Paik also invented a proprietary stomach cancer technique to reduce reflux disease risk.
The doctor is the Director of the Yonsei Cancer Center at Yonsei University Health System in Seoul, South Korea. Specializing in the treatment of advanced gastric cancer, the doctor has extensive expertise in surgery, oncology, and gastroenterology.
The doctor has held prestigious positions such as President of the Korean Gastric Cancer Association and the International Gastric Cancer Association, and Chairman of the Board of the Korean Cancer Association and the Korean Surgical Society.
Recognized as an outstanding surgeon in gastric cancer surgery, the doctor has received numerous accolades, including the Cancer Academic Award and the Yuhan Academic Award.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Samsung Medical Center, Seoul National University Hospital (SNUH), and Asan Medical Center are the premier hospitals for small intestine cancer treatment in South Korea. These JCI-accredited tertiary centers provide multidisciplinary oncology teams. They utilize advanced PET/CT imaging and robotic surgical systems for complex tumor resections.
Bookimed Expert Insight: While patients often seek famous names, our data shows institutional capacity is the real quality signal. Asan Medical Center manages over 182,000 oncology patients yearly. This massive volume ensures surgeons see rare small intestine cases frequently. This level of specialization is often unavailable in smaller regional clinics.
Patient Consensus: Patients emphasize finding a hospital that conducts pathology reviews in-house to ensure accurate staging. Many note that choosing centers with dedicated international departments significantly simplifies scheduling and translation during complex treatments.
South Korea offers multi-stage small intestine cancer treatment including surgical resection, advanced chemotherapy, and robotic surgery. Specialized centers utilize Da Vinci systems and laparoscopic techniques for localized tumors. Systemic options include HIPEC, immunotherapy (Keytruda), and targeted therapies for specific subtypes like neuroendocrine tumors or adenocarcinoma.
Bookimed Expert Insight: While many choose Asan Medical Center for its massive 2,700-bed capacity, Seoul National University Hospital often sees the highest-ranking officials due to its historical reputation. If you require robotic surgery, Korea University Anam Hospital is a strategic choice because they pioneered several robotic surgical firsts in Asia.
Patient Consensus: Patients note that verifying the tumor subtype early is vital because treatment plans for adenocarcinoma differ significantly from GIST or neuroendocrine tumors. They also recommend seeking care at centers with dedicated gastrointestinal oncology teams for the best coordination.
South Korea reports global-leading 5-year survival rates for gastrointestinal cancers, exceeding 75% for bowel and 76% for stomach malignancies. These outcomes often surpass US and European averages. High-volume tertiary centers in Seoul utilize PET-CT and Da Vinci robotic systems within JCI-accredited facilities to improve results.
Bookimed Expert Insight: Patient volume is the strongest predictor of success for rare small intestine cancers in Korea. Asan Medical Center treats over 14,000 patients daily, ensuring surgeons handle more rare GI cases in a month than many Western specialists see in a year. This concentrated experience directly leads to more accurate staging and fewer surgical complications.
Patient Consensus: Patients note that major Korean hospitals act quickly with imaging and surgery. They emphasize ensuring your case is reviewed by a multidisciplinary tumor board for the most accurate pathology results.
Korean oncology centers offer advanced robotic and minimally invasive surgery for small intestine cancer. Facilities like Samsung Medical Center use da Vinci systems for precise tumor resection. Surgeons frequently employ laparoscopic or robotic-assisted techniques to treat localized malignancies with smaller incisions and faster recovery.
Bookimed Expert Insight: While most elite centers focus on volume, Korea University Anam Hospital stands out for specialized robotic precision. It developed the first robotic oral thyroid surgery and leads in complex reconstructions. This technical mastery often translates to better handling of difficult small intestine tumor locations. You should prioritize centers with documented robotic experience in varied abdominal oncology rather than just surgery volume.
Patient Consensus: Patients note that robotic options are routine in Seoul but emphasize that surgeons decide on the technique based on tumor size and depth. They often advise bringing full pathology reports to help surgeons determine if a minimally invasive approach is realistic.
International patients can join small intestine cancer clinical trials in South Korea. The country serves as a global oncology hub with high-volume multinational studies. Eligibility depends on trial protocols, hospital policies, and sponsorship. Major facilities like Samsung Medical Center and Asan Medical Center host these advanced research programs.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and handles over 45,000 surgeries. This massive volume drives their involvement in phase II and III trials. Patients should target these high-capacity centers. They often have dedicated research coordinators for international participants. This infrastructure simplifies enrollment and provides access to global therapeutics.
Patient Consensus: Patients note that logistics like frequent scans and local addresses are common hurdles. Reliable translation services are critical for understanding consent forms and maintaining trial eligibility.
Ask about the surgical resectability of the tumor and the specific involvement of nearby lymph nodes. Confirm the pathology results, including tumor grade and margins. In Korea, verify if a multidisciplinary tumor board at a JCI-accredited facility will review your treatment plan.
Bookimed Expert Insight: South Korean oncology centers like Seoul National University Hospital and Samsung Medical Center maintain some of the highest cancer treatment statistics globally. A major differentiator is their high-volume capacity, with some clinics treating over 10,000 patients daily. When discussing your plan, ask specifically about the internal coordinator system. These digitalized hospitals use advanced tracking to ensure seamless communication between surgical and oncology departments.
Patient Consensus: Patients emphasize the need to clarify how the surgery will impact daily eating habits and long-term vitamin absorption. Many also suggest asking about symptoms that require urgent care, like bowel obstructions or sudden dehydration.